Review
Copyright ©2013 Baishideng Publishing Group Co.
World J Hepatol. Nov 27, 2013; 5(11): 603-611
Published online Nov 27, 2013. doi: 10.4254/wjh.v5.i11.603
Table 1 Risk stratification and need for cytomegalovirus prophylaxis
Donor CMV IgG statusRecipient CMV IgG statusRisk type1Need for CMV prophylaxis
PositivePositiveLow riskLow
PositiveNegativeHigh riskHigh
NegativePositiveLow riskLow
NegativeNegativeLow riskLow